India's Emcure Pharmaceuticals falls after block deals at discount
** Shares of Emcure Pharmaceuticals EMCU.NS fall 2.3% to 1,249.90 rupees ** More than 4.7 mln shares traded in four block deals on NSE at a discount of 0.3% to 2.1% ** BC Investments IV likely to sell 2.4% stake in EMCU via block deal, CNBC-TV18 reported on Thursday, citing sources ** BC Investments IV held 8.68% stake as on March 31, as per exchange data ** Stock falls for third straight week ** EMCU down ~14% YTD (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees